Substrate Selection in Homologous Bacterial Transporters
同源细菌转运蛋白的底物选择
基本信息
- 批准号:6753938
- 负责人:
- 金额:$ 20.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Solute transporters are defective in genetic diseases and confer bacterial and cancer drug resistance. Transporters have substrate specificity, which is poorly understood, thus hindering our understanding of transport. It is unclear whether amino acids that confer sugar specificity in the lactose permease of E. coli (LacY) also confer sugar selection in homologous transporters for melibiose (MelY), raffinose (RafB) and sucrose (CseB). Until solute specificity is understood in homologous transporters, it will be difficult to know how transport is accomplished. The long range goal is to understand the molecular basis of substrate recognition during transport. The specific objective of this research is to determine whether (the molecular properties) the solute binding sites in homologous solute transporters differ in their amino acids that determine specificities. The central hypothesis is that functional differences between transporters (i.e., solute specificities) are dictated by subtle differences in sequence (and thus, structure), since the seemingly diverse transporters share related amino acid sequences. The rationale for the proposed research is that once it is known whether homologous sugar transporters mediate substrate specificity by similar or distinct binding and transport properties, we will know whether a common molecular basis exists for transport in seemingly diverse transporters, and the potential will exist for engineering transporters to translocate highly desirable solutes for therapeutic purposes. The solute specificity profiles for MelY RafB and CscB homologues are distinct and thus make our experimental system unique for a comparative study of substrate specificity. The specific aims are independent of the completion of one another. Specific Aim 1: Identify amino acid residues that determine sucrose transport in MelY. We propose to isolate and characterize mutants containing MelY that transport sucrose. In preliminary work, we have found several sucrose fermentation positive mutants. We have published data showing mutations in helices 3 and 6 of MelY that transport maltose. Specific Aim 2: Identify amino acids that determine sucrose and maltose transport in RafB. We propose to isolate and characterize RafB mutants that transport sucrose. We isolated maltose positive mutants; we will study maltose uptake and accumulation in these mutants using transport assays. We have preliminary data showing that RafB has distinct binding sites for raffinose and lactose. Specific Aim 3: Identify residues that determine melibiose and maltose transport in CscB. We will isolate cells with mutated CscB that transport melibiose or maltose, and then study transport. We have found maltose positive mutants. We have preliminary data showing that CscB transports lactose. The comparative nature of the study of solute specificity in homologous transporters is innovative, as most other studies focus on solute binding and transport of naturally occurring substrates. Data generated by the proposed work will be innovative because MelY, RafB and CscB are homologous to many transporters, and knowledge of solute specificity mechanisms gained here will be applicable to transporters involved in genetic diseases and to infectious disease-causing bacteria and their drug resistances.
描述(申请人提供):溶质转运蛋白在遗传性疾病中有缺陷,并对细菌和癌症产生耐药性。转运蛋白具有底物特异性,人们对此知之甚少,因此阻碍了我们对转运蛋白的理解。目前尚不清楚在大肠杆菌乳糖渗透酶(Lacy)中赋予糖专一性的氨基酸是否也赋予梅二糖(MELY)、棉子糖(RAFB)和蔗糖(CseB)的同源转运体中的糖选择。在了解同源转运蛋白中的溶质专一性之前,很难知道转运蛋白是如何完成的。长期目标是了解运输过程中底物识别的分子基础。这项研究的具体目标是确定同源溶质转运体中的溶质结合部位是否(分子性质)在决定特异性的氨基酸上有所不同。中心假设是转运蛋白之间的功能差异(即溶质特异性)是由序列(从而结构)的细微差异决定的,因为看似不同的转运蛋白共享相关的氨基酸序列。这项研究的基本原理是,一旦知道同源糖转运蛋白是否通过相似或不同的结合和运输性质来调节底物特异性,我们就会知道在看似不同的转运蛋白中是否存在共同的转运分子基础,以及工程转运蛋白出于治疗目的转运非常理想的溶质的可能性。Mely RAFB和CSCB同系物的溶质特异性曲线是不同的,因此使我们的实验系统对于底物特异性的比较研究是独一无二的。具体的目标是彼此独立完成的。具体目标1:确定决定蔗糖转运的氨基酸残基。我们建议分离和鉴定含有转运蔗糖的MELY的突变体。在前期工作中,我们发现了几株蔗糖发酵阳性突变株。我们已经发表的数据显示,Mely的3号和6号螺旋结构中运输麦芽糖的突变。具体目标2:确定决定RAFB中蔗糖和麦芽糖运输的氨基酸。我们建议分离和鉴定运输蔗糖的RAFB突变体。我们分离了麦芽糖阳性突变株;我们将使用转运试验研究这些突变株对麦芽糖的吸收和积累。我们有初步数据显示RAFB与棉子糖和乳糖有不同的结合部位。具体目标3:确定决定棉铃糖和麦芽糖在CSCB中运输的残留物。我们将用突变的CSCB分离运输蜜二糖或麦芽糖的细胞,然后研究运输。我们发现了麦芽糖阳性突变体。我们有初步数据显示CSCB运输乳糖。同源转运体中溶质专一性研究的比较性质是创新的,因为大多数其他研究侧重于溶质结合和自然发生的底物的运输。拟议工作产生的数据将是创新的,因为MELY、RAFB和CSCB与许多转运蛋白同源,这里获得的溶质特异性机制知识将适用于涉及遗传病的转运蛋白以及导致传染病的细菌及其耐药性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MANUEL F VARELA其他文献
MANUEL F VARELA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MANUEL F VARELA', 18)}}的其他基金
MULTI-DRUG RESISTANCE IN STAPHYLOCOCCUS AUREUS CLINICAL ISOLATES
金黄色葡萄球菌临床分离株的多重耐药性
- 批准号:
8359749 - 财政年份:2011
- 资助金额:
$ 20.91万 - 项目类别:
MULTI-DRUG RESISTANCE IN STAPHYLOCOCCUS AUREUS CLINICAL ISOLATES
金黄色葡萄球菌临床分离株的多重耐药性
- 批准号:
8167572 - 财政年份:2010
- 资助金额:
$ 20.91万 - 项目类别:
BACTERIAL SOLUTE TRANSPORTERS: MOLECULAR BASIS FOR SUGAR
细菌溶质转运蛋白:糖的分子基础
- 批准号:
6972150 - 财政年份:2004
- 资助金额:
$ 20.91万 - 项目类别:
相似海外基金
ALPHA CONOTOXIN BINDING SITES ON NICOTINIC ACH RECEPTOR
烟碱 ACH 受体上的α芋螺毒素结合位点
- 批准号:
6564579 - 财政年份:2002
- 资助金额:
$ 20.91万 - 项目类别:
CHARACTERIZATION OF ANTIARRHYTHMIC DRUG BINDING SITES IN VOLTAGE GATED CHANNELS
电压门控通道中抗心律失常药物结合位点的表征
- 批准号:
6110344 - 财政年份:1999
- 资助金额:
$ 20.91万 - 项目类别:
CHARACTERIZATION OF ANTIARRHYTHMIC DRUG BINDING SITES IN VOLTAGE GATED CHANNELS
电压门控通道中抗心律失常药物结合位点的表征
- 批准号:
6272960 - 财政年份:1998
- 资助金额:
$ 20.91万 - 项目类别:
CHARACTERIZATION OF ANTIARRHYTHMIC DRUG BINDING SITES IN VOLTAGE GATED CHANNELS
电压门控通道中抗心律失常药物结合位点的表征
- 批准号:
6242338 - 财政年份:1997
- 资助金额:
$ 20.91万 - 项目类别:
LIGAND BINDING SITES OF THE ACETYLCHOLINE RECEPTOR
乙酰胆碱受体的配体结合位点
- 批准号:
6321343 - 财政年份:1996
- 资助金额:
$ 20.91万 - 项目类别:
LIGAND BINDING SITES OF THE ACETYLCHOLINE RECEPTOR
乙酰胆碱受体的配体结合位点
- 批准号:
6393797 - 财政年份:1996
- 资助金额:
$ 20.91万 - 项目类别:
LIGAND BINDING SITES OF THE ACETYLCHOLINE RECEPTOR
乙酰胆碱受体的配体结合位点
- 批准号:
6187300 - 财政年份:1996
- 资助金额:
$ 20.91万 - 项目类别:
LIGAND BINDING SITES OF THE ACETYLCHOLINE RECEPTOR
乙酰胆碱受体的配体结合位点
- 批准号:
6539876 - 财政年份:1996
- 资助金额:
$ 20.91万 - 项目类别:
LIGAND BINDING SITES OF THE ACETYLCHOLINE RECEPTOR
乙酰胆碱受体的配体结合位点
- 批准号:
2902701 - 财政年份:1996
- 资助金额:
$ 20.91万 - 项目类别:














{{item.name}}会员




